Top Qs
Timeline
Chat
Perspective

Meier-Gorlin syndrome

Medical condition From Wikipedia, the free encyclopedia

Meier-Gorlin syndrome
Remove ads

Meier-Gorlin syndrome, also known as Ear-patella-short stature syndrome is a rare autosomal recessive genetic disorder, which is mainly characterized by pre- and postnatal growth deficiency, patellar aplasia or hypoplasia, and underdevelopment of both ears.[1][2] Patients have characteristic facial signs, such as small mouth with full lips, receding jaw, hooked nose, and small ears with abnormal shape.[3] Meier-Gorlin syndrome is considered to be one of the forms of microcephalic primordial dwarfism.[4]

Quick facts Other names, Symptoms ...

Less than 150 cases have been recorded as of 2024.[5]

Remove ads

Symptoms

Summarize
Perspective
Thumb
Side-view illustration of a baby with microcephaly (left) compared to a baby with a normal head size.

The classic triad of this disorder consist of pre- and postnatal growth deficiency, patellar aplasia or hypoplasia, and underdevelopment of both ears.[1][6]

Patellar and microtia are present in almost all patients, the severity of microtia can range from mild to severe, and ears can appear underdeveloped and low-set. Also, microtia can be accompinied by stenosis of the external auditory canal and conduction deafness, and patellas are absent in most patients, but in some cases, patellas might be hypoplastic.[6][7] Most of the patients had IUGR (Intrauterine growth restriction) and consequently had delayed growth after birth, and growth velocity was nearly normal after.[3] Another most common feature is microcephaly.[3]

Most of the patients have normal intellectual functioning, altough some of the patients had developmental delays without ID, only one had mild ID.[6][7]

Female patients usually experience underdevelopment of breast tissue, and some patients have abnormal genitalia (such as hypoplastic labia minora or majora, cryptorchidism).[8] Also, secondary sex characteristics development was also affected in some patients (lack of axillary hair/pubic hair).[3] Pulmonary emphysema can also be seen in some cases.[8]

Craniosynostosis is mainly associated with CDC45L (MGORS7) mutations.[9] [10]

Remove ads

Diagnosis

MGORS can be suspected by having one of the classic signs (such as microtia) and it can be confirmed by genetic testing.[8]

Cause

MGORS is a heterogenous disorder (which means that different gene mutations cause the same disroder), and MGS can be caused by mutation in these genes:[11][12]

More information Type, Gene ...

Note: MGORS6 is an autosomal dominant form of MGORS.[13]

Pathophysiology

Summarize
Perspective

Pre-replication complex is an important protein complex, which consist of 6 subunits of Origin Recognition Complex (ORC1, ORC2, ORC3, ORC4, ORC5 and ORC6 genes), CDC6, CDT1, and MCM2-7 (MCM2, MCM3, MCM4, MCM5, MCM6, MCM7).[14][15] This complex is loaded on so called origins of replication in early M phase into G1 phase, which is important for the cell cycle[16][17] CDC45L is also part of the pre-replication complex and CMG helicase complex, which is important for the beginning of DNA replication.[9]

In case of MGORS, these proteins usually lose their function, which impairs the rate of the cell cycle and causes growth restriction.[18] GMNN mutations are autosomal dominant gain-of-function mutations, which cause hyperactivation of the protein, and it inhibits replication much longer through CDT1 destruction.[19]

According to one study, some proteins (which mutations are linked to MGORS) have non-canonical function, such as ORC6 stimulates separation of two daughter cells during cytokinesis and it also participates in MMR during DNA replication. Also, CDT1 stabilizes kinetochore-microtubule interactions during M phase. ORC1 regulates centrosome and centriole replication through two separate domain interaction.[18]

Remove ads

Treatment

Thumb
This photo shows normal alveoli and alveoli with emphysema.

Although Meier-Gorlin syndrome doesn't have a cure, it can be managed. Mainly management is focused on growth retardation, hearing loss, floating kneecap, feeding issues, gonarthrosis, pain in the knee, and pulmonary problems due to congenital pulmonary emphysema with or without broncho-/laryngomalacia.[6]

Growth hormone therapy had been tried, although it was effective only in some cases.[6][3]

Remove ads

History

MGORS was first described by Meier and colleagues in 1959, and later by Meier and colleagues in 1975.[20][21]

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads